id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-320599-hxn4bgec	Liontos, Michalis	Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19	2020-07-30		.txt	text/plain	805	78	53	title: Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19 • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently. 42 We present the case of an ovarian cancer patient who successfully resumed her 43 chemotherapy immediately after the diagnosis and hospitalization for COVID-19 44 pneumonia. The patient was initially diagnosed 20 months ago with stage IIIc high grade serous 50 ovarian cancer and was treated with primary debulking surgery and frontline treatment 51 with Paclitaxel, Carboplatin and Bevacizumab. Following national 68 guidance during COVID-19 pandemic, the patient was tested for SARS-Cov-2 and the 69 PCR was positive. Two subsequent PCR tests for 77 SARS-CoV-2, performed 24 hours apart were negative and the patient was discharged 78 after 12 days of hospitalization. Cancer guidelines during the COVID-19 pandemic. Lower detection rates of SARS-COV2 antibodies in cancer 172 patients vs healthcare workers after symptomatic COVID-19	./cache/cord-320599-hxn4bgec.txt	./txt/cord-320599-hxn4bgec.txt